Transient inhibition of translation improves long-term cardiac function after ischemia/reperfusion by attenuating the inflammatory response
Christoph P. Hofmann(Heidelberg University), Mirko Völkers(Heidelberg University), Verena Kamuf‐Schenk(Heidelberg University), Fereshteh S. Younesi(St. Michael's Hospital), Ellen Malovrh(Heidelberg University), Hugo A. Katus(Heidelberg University), Frank Stein(European Molecular Biology Organization), Florian Leuschner(Heidelberg University), Claudia Stroh(Heidelberg University), Mandy Rettel(European Molecular Biology Organization), Adrian Serafin(Heidelberg University), Clara Sandmann(Heidelberg University), Ole M Schwerdt(Heidelberg University), Zoe Löwenthal(Heidelberg University), Florian Sicklinger(Heidelberg University), Ingmar Sören Meyer(Heidelberg University), Tobias Jakobi(Heidelberg University), Lonny Jürgensen(Heidelberg University), Norbert Frey(Heidelberg University)
Cited by 1
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
European Society of Cardiology: cardiovascular disease statistics 2021
|European Heart Journal|2021|1.1k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k